These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A novel CLN2/TPP1 mutation in a patient with late infantile neuronal ceroid lipofuscinosis. Yu F; Liu XM; Chen YH; Zhang SQ; Wang K Neurol Sci; 2015 Oct; 36(10):1917-9. PubMed ID: 26032578 [No Abstract] [Full Text] [Related]
4. Batten disease: biochemical and molecular characterization revealing novel PPT1 and TPP1 gene mutations in Indian patients. Sheth J; Mistri M; Bhavsar R; Pancholi D; Kamate M; Gupta N; Kabra M; Mehta S; Nampoothiri S; Thakker A; Jain V; Shah R; Sheth F BMC Neurol; 2018 Dec; 18(1):203. PubMed ID: 30541466 [TBL] [Abstract][Full Text] [Related]
5. Interactions of the proteins of neuronal ceroid lipofuscinosis: clues to function. Getty AL; Pearce DA Cell Mol Life Sci; 2011 Feb; 68(3):453-74. PubMed ID: 20680390 [TBL] [Abstract][Full Text] [Related]
6. Diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): Expert recommendations for early detection and laboratory diagnosis. Fietz M; AlSayed M; Burke D; Cohen-Pfeffer J; Cooper JD; Dvořáková L; Giugliani R; Izzo E; Jahnová H; Lukacs Z; Mole SE; Noher de Halac I; Pearce DA; Poupetova H; Schulz A; Specchio N; Xin W; Miller N Mol Genet Metab; 2016 Sep; 119(1-2):160-7. PubMed ID: 27553878 [TBL] [Abstract][Full Text] [Related]
7. An integrated strategy for the diagnosis of neuronal ceroid lipofuscinosis types 1 (CLN1) and 2 (CLN2) in eleven Latin American patients. Kohan R; Cismondi IA; Kremer RD; Muller VJ; Guelbert N; Anzolini VT; Fietz MJ; Ramírez AM; Halac IN Clin Genet; 2009 Oct; 76(4):372-82. PubMed ID: 19793312 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and molecular characterization of neuronal ceroid lipofuscinosis in the Portuguese population. Teixeira C; Guimarães A; Bessa C; Ferreira MJ; Lopes L; Pinto E; Pinto R; Boustany RM; Sá Miranda MC; Ribeiro MG J Neurol; 2003 Jun; 250(6):661-7. PubMed ID: 12796825 [TBL] [Abstract][Full Text] [Related]
10. Homozygous missense TPP1 mutation associated with mild late infantile neuronal ceroid lipofuscinosis and the genotype-phenotype correlation. Chen ZR; Liu DT; Meng H; Liu L; Bian WJ; Liu XR; Zhu WW; He Y; Wang J; Tang B; Su T; Yi YH Seizure; 2019 Jul; 69():180-185. PubMed ID: 31059981 [TBL] [Abstract][Full Text] [Related]
11. A novel CLN2/TPP1 mutation in a Chinese patient with late infantile neuronal ceroid lipofuscinosis. Wang YL; Zeng ZY; Song XW; Hao ZF; Shi YW; Tang B; Chen SQ; Gao MM; Di W; Long YS; Yi YH; Liao WP Neurogenetics; 2011 Feb; 12(1):93-5. PubMed ID: 20820830 [No Abstract] [Full Text] [Related]
12. Lysosomal protein thermal stability does not correlate with cellular half-life: global observations and a case study of tripeptidyl-peptidase 1. Collier AM; Nemtsova Y; Kuber N; Banach-Petrosky W; Modak A; Sleat DE; Nanda V; Lobel P Biochem J; 2020 Feb; 477(3):727-745. PubMed ID: 31957806 [TBL] [Abstract][Full Text] [Related]
14. Upregulation of tripeptidyl-peptidase 1 by 3-hydroxy-(2,2)-dimethyl butyrate, a brain endogenous ligand of PPARα: Implications for late-infantile Batten disease therapy. Chakrabarti S; Chandra S; Roy A; Dasarathi S; Kundu M; Pahan K Neurobiol Dis; 2019 Jul; 127():362-373. PubMed ID: 30928643 [TBL] [Abstract][Full Text] [Related]
15. Moving towards effective therapeutic strategies for Neuronal Ceroid Lipofuscinosis. Geraets RD; Koh Sy; Hastings ML; Kielian T; Pearce DA; Weimer JM Orphanet J Rare Dis; 2016 Apr; 11():40. PubMed ID: 27083890 [TBL] [Abstract][Full Text] [Related]
16. Enzyme replacement therapy attenuates disease progression in a canine model of late-infantile neuronal ceroid lipofuscinosis (CLN2 disease). Katz ML; Coates JR; Sibigtroth CM; Taylor JD; Carpentier M; Young WM; Wininger FA; Kennedy D; Vuillemenot BR; O'Neill CA J Neurosci Res; 2014 Nov; 92(11):1591-8. PubMed ID: 24938720 [TBL] [Abstract][Full Text] [Related]
17. Intrathecal tripeptidyl-peptidase 1 reduces lysosomal storage in a canine model of late infantile neuronal ceroid lipofuscinosis. Vuillemenot BR; Katz ML; Coates JR; Kennedy D; Tiger P; Kanazono S; Lobel P; Sohar I; Xu S; Cahayag R; Keve S; Koren E; Bunting S; Tsuruda LS; O'Neill CA Mol Genet Metab; 2011 Nov; 104(3):325-37. PubMed ID: 21784683 [TBL] [Abstract][Full Text] [Related]
18. Mutation update: Review of TPP1 gene variants associated with neuronal ceroid lipofuscinosis CLN2 disease. Gardner E; Bailey M; Schulz A; Aristorena M; Miller N; Mole SE Hum Mutat; 2019 Nov; 40(11):1924-1938. PubMed ID: 31283065 [TBL] [Abstract][Full Text] [Related]